The Wuhan Coronavirus Is Spreading Fast. Will Doctors Be Able to Find a Treatment Before the Outbreak Ends?
Cases of a novel pneumonia-like illness that originated in Wuhan, China in December have now been confirmed in South Korea, Thailand, Japan, Taiwan, Macau—and, as of Jan. 21, the U.S. The virus’ geographic reach, as well as its newly discovered ability to spread via person-to-person contact, has health officials worried about the prospect of globals spread. As health officials scramble to learn more about the virus and is origins, researchers are simultaneously turning to the question of how to develop a vaccine or therapy that could help contain transmission worldwide—a feat that experts say is technically possible, but logistically more complex. The Wuhan virus belongs to the coronavirus family, a category that includes Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) and that typically results in respiratory illnesses. While SARS and the new coronavirus are not identical, their similarities could make it easier to “cannibalize” prior research and start developing vaccines and therapeutics on an accelerated timeline, says Ralph Baric, who researches coronaviruses at the University of North Carolina Gillings School of Global Public Health. Following the SARS outbreak in 2003, researchers produced a vaccine that made it to phase one human trials, which test the safety of a new drug. But the effort never progressed further, mainly due to shifting research priorities as the outbreak came to an end, says Dr. Anth...
Many treatments exist for RA, but methods for determining which to use for a given patient are sorely lacking, said the lead researcher of a new study on a precision approach: synovial tissue biopsy.Medscape Medical News
CONCLUSIONS: ILIT was safe and effective for Japanese cedar pollinosis. The clinical effects remained for 1-2 years. PMID: 32091032 [PubMed - as supplied by publisher]
In conclusion, our results reveal that CNMs target the HIF-1α/VEGF pathway, which may be an important reason for the suppression of retinoblastoma growth and angiogenesis. PMID: 32091275 [PubMed - in process]
Dr William Balistreri explains what many people still get wrong when they decide to'go against the grain. 'Medscape Gastroenterology
George SelginThis morning, upon logging in to my Twitter account, I found it brimming with reports that the Hong Kong government was about to embark upon an unprecedented experiment with helicopter money. " Helicopter Money is Here, " blurtsanFT Alphavilleheadline. " Hong Kong Embraces Helicopter Money, "saysZero Hedge. The foreign press has also chimed in: " Helicopter Money Comincia a Hong Kong, " writesItalian financial journalist Maurizio Blondet.In typically understated fashion,Zero Hedge' s report concludes thus:So Hong Kong is about to unleash the mother of all stagflations on its peopl...
Partisan divisions in favorable opinion of the ACA have gotten larger rather than smaller over time
Publication date: Available online 26 February 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Hirotsugu Oda, Hiroyuki Wakabayashi, Miyuki Tanaka, Koji Yamauchi, Chihiro Sugita, Hiroki Yoshida, Fumiaki Abe, Tohru Sonoda, Masahiko Kurokawa
Authors: Bergeron HC, Tripp RA Abstract Introduction. Respiratory syncytial virus (RSV) causes lower respiratory tract infections and can lead to morbidity and mortality in the infant, elderly and immunocompromised. There is no vaccine and therapeutic interventions are limited. RSV disease research has yielded the development of several prophylactic and therapeutic treatments. Several promising candidates are currently under investigation.Areas covered. Small and large molecule approaches to RSV treatment were examined and categorized by their mechanism of action using data from PubMed, clinicaltrials.gov, and from...
When Dr. Tushar Kothari joined Radiology Associates of Northern Kentucky in 1999, the medical practice included about 20 physicians. Now, with 34 doctors, it ’s one of the largest in the region – and continuing to expand.
Publication date: April 2020Source: Fish &Shellfish Immunology, Volume 99Author(s): Mostafa Halimi, Mojtaba Alishahi, Mohammad Reza Abbaspour, Masoud Ghorbanpoor, Mohammad Reza Tabandeh
More News: African Health | Allergy | Allergy & Immunology | Biotechnology | China Health | Common Cold | Congo Health | Coronavirus | Ebola | Ebola Vaccine | Emergency Medicine | Health | Infectious Diseases | International Medicine & Public Health | Japan Health | Learning | Macau Health | MERS | Middle East Health | Outbreaks | Pneomococcal Vaccine | Pneumonia | Respiratory Medicine | SARS | Science | South Korea Health | Study | Taiwan Health | Thailand Health | Universities & Medical Training | Vaccines | Veterinary Vaccinations